Previous 10 | Next 10 |
home / stock / lzagy / lzagy news
The following slide deck was published by Lonza Group Ltd in conjunction with their 2021 Q2 earnings call. For further details see: Lonza Group Ltd 2021 Q2 - Results - Earnings Call Presentation
Lonza Group AG (LZAGY): 1H Non-GAAP EPS of CHF6.97; GAAP EPS of CHF3.50.Revenue of CHF2.54B (+13.4% Y/Y)Press Release For further details see: Lonza Group AG reports 1H results
Photo by Carl Court/Getty Images News via Getty Images Moderna ([[MRNA]] +4.7%) hit a 52-week high today on the news of an additional agreement with Swiss contract manufacturer Lonza ([[LZAGY]] +0.3%) to ramp up the drug substance manufacturing for its global supply chain. The highl...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. The current low-quality rally offers an opportunity to look back on the lessons from the last time the markets coo...
Gracell Biotechnologies (GRCL) has signed a Manufacturing Service Agreement with Lonza (LZAGY) for clinical manufacturing of Gracell's CAR-T cell product candidates in the U.S.Lonza is an ‘ideal strategic collaborator for advancing our pioneering, proprietary FasTCAR platform...
Lonza Group Ltd (LZAGY) Q4 2020 Earnings Conference Call January 27, 2021 08:30 AM ET Company Participants Pierre-Alain Ruffieux - CEO Rodolfo Savitzky - CFO Conference Call Participants Patrick Wood - Bank of America Jo Walton - Crédit Suisse Richard Vosser - JPMorgan KC Arikatla - Gold...
Lonza Group is the second deep dive in my CDMO industry series. The company prospered in 2020 and will narrow its focus in 2021. Focusing on its manufacturing and services segment will increase margins and sales growth. Company guidance suggests growth is just starting, as cap...
NextPharma to broaden technology offering into lipid finished dosage forms by potential acquisition of Lonza ([[LZAGY]] -1.2%) sites in Ploermel (France) and Edinburgh, UK.The agreement is subject to relevant conditions and regulatory approvals and where applicable, both parties will consult ...
Coronavirus vaccine makers have quickly turned to a network of smaller, lesser-known manufacturers to mount an unprecedented effort to produce their shots at a record pace, WSJ reports.While new mRNA technology makes industrialization easier than a traditional vaccine - since manufacturers do...
iSpecimen has filed to raise $20 million in an IPO. The firm operates a human biospecimen online marketplace. ISPN has grown from a small revenue base and operates in a promising industry, so I look forward to learning about the IPO's pricing and valuation assumptions. For f...
News, Short Squeeze, Breakout and More Instantly...
Lonza Group AG ADR Company Name:
LZAGY Stock Symbol:
OTCMKTS Market:
NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass. , May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today ...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
Lonza Group AG ADR (LZAGY) is expected to report for Q4 2023